摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-methyl-7-fluoro-1,2,3-benzoxathiazine 2,2-dioxide | 1025506-12-0

中文名称
——
中文别名
——
英文名称
4-methyl-7-fluoro-1,2,3-benzoxathiazine 2,2-dioxide
英文别名
——
4-methyl-7-fluoro-1,2,3-benzoxathiazine 2,2-dioxide化学式
CAS
1025506-12-0
化学式
C8H6FNO3S
mdl
——
分子量
215.205
InChiKey
AHCIPKOLAKWPDW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    356.2±44.0 °C(Predicted)
  • 密度:
    1.56±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.27
  • 重原子数:
    14.0
  • 可旋转键数:
    0.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    55.73
  • 氢给体数:
    0.0
  • 氢受体数:
    3.0

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Enantioselective Synthesis of Cyclic Sulfamidates via Pd-Catalyzed Hydrogenation
    摘要:
    Using Pd(CF3CO2)(2)/(SS)-f-binaphane as the catalyst, an efficient enantioselective synthesis of cyclic sulfamidates was developed via asymmetric hydrogenation of the corresponding cyclic imines in 2,2,2-trifluoroethanol at room temperature with high enantioselectivities (up to 99% ee).
    DOI:
    10.1021/ol800591u
  • 作为产物:
    描述:
    4-氟-2-羟基苯乙酮甲酸氯磺酰异氰酸酯 、 sodium hydride 作用下, 以 N,N-二甲基乙酰胺 、 mineral oil 为溶剂, 以46%的产率得到4-methyl-7-fluoro-1,2,3-benzoxathiazine 2,2-dioxide
    参考文献:
    名称:
    Enantioselective Synthesis of Cyclic Sulfamidates via Pd-Catalyzed Hydrogenation
    摘要:
    Using Pd(CF3CO2)(2)/(SS)-f-binaphane as the catalyst, an efficient enantioselective synthesis of cyclic sulfamidates was developed via asymmetric hydrogenation of the corresponding cyclic imines in 2,2,2-trifluoroethanol at room temperature with high enantioselectivities (up to 99% ee).
    DOI:
    10.1021/ol800591u
点击查看最新优质反应信息

文献信息

  • Organocatalytic Enantioselective Formal [4 + 2] Cycloaddition of Enones with Cyclic <i>N</i>-Sulfonylimines and Methylene Chromene for Chiral Spirocyclic Compounds
    作者:Jie Fei、Qingqing Qian、Xiaohua Sun、Xiaodong Gu、Chuncheng Zou、Jinxing Ye
    DOI:10.1021/acs.orglett.5b02667
    日期:2015.11.6
    A highly enantioselective synthesis of spirocycles and bridged rings has been developed through a formal [4 + 2] cycloaddition reaction between enones and N-sulfonylimines. The unprecedented strategy has been realized utilizing N-sulfonylimine as a novel dienophile through enamine–iminium tautomerism of N-sulfonylimine. In addition, a γ,ε-regioselective cycloaddition reaction proceeded by employing
    通过烯酮和N-磺酰亚胺之间的正式[4 + 2]环加成反应,已经开发出螺环和桥环的高度对映选择性合成。通过N-磺酰胺的烯胺-亚胺互变异构现象,将N-磺酰胺作为一种新型的亲二烯体,已经实现了前所未有的策略。另外,通过使用亚甲基色烯物种作为亲双烯体进行γ,ε-区域选择性环加成反应。
  • Asymmetric Domino Reaction of Cyclic <i>N</i>-Sulfonylimines and Simple Aldehydes with <i>trans</i>-Perhydroindolic Acid as an Organocatalyst
    作者:Qianjin An、Jiefeng Shen、Nicholas Butt、Delong Liu、Yangang Liu、Wanbin Zhang
    DOI:10.1021/ol502033v
    日期:2014.9.5
    An asymmetric domino reaction was developed utilizing readily available cyclic N-sulfonylimines and simple aldehydes to construct biologically important and synthetically challenging piperidine derivatives consisting of three contiguous stereocenters. trans-Perhydroindolic acid proved to be an efficient organocatalyst in this reaction (up to 89% yield, 80:20 dr, and 99% ee). The absolute configuration
    利用容易获得的环状N-磺酰亚胺类化合物和简单的醛,开发了一个不对称的多米诺反应,以构建生物学上重要且具有合成挑战性的由三个连续的立体中心组成的哌啶生物。反-过氢吲哚酸被证明是该反应中有效的有机催化剂(产率高达89%,80:20 dr和99%ee)。催化产物的绝对构型通过X射线晶体学研究确定。可以通过简单的转化将产物方便地转化为合成上有用的中间体,例如(3 R,4 S)-4-乙基-3-甲基-6-苯基哌啶基吡啶-2-酮(8)。
  • N‐Heterocyclic Carbene Catalyzed Asymmetric Synthesis of Pentacyclic Spirooxindoles via [3+3] Annulations of Isatin‐Derived Enals and Cyclic N‐Sulfonyl Ketimines
    作者:Qiang Liu、Xiang‐Yu Chen、Sun Li、Kari Rissanen、Dieter Enders
    DOI:10.1002/adsc.201900065
    日期:2019.4.23
    A convenient enantioselective route to new types of pentacyclic spirooxindoles via [3+3] annulation reactions of isatin‐derived enals and cyclic N‐sulfonyl ketimines, using N‐heterocyclic carbene (NHC) catalysis has been developed. The new protocol leads to pentacyclic spirooxindoles bearing a quaternary spiro‐stereocenter in good yields and good to high enantiomeric ratios.
    通过使用N-杂环卡宾(NHC)催化,通过伊斯兰衍生的烯类和环状N-磺酰基酮亚胺的[3 + 3]环化反应,已开发出一种便捷的对映异构途径,以合成新型五环螺氧并吲哚。新规程导致五环螺氧杂环辛酮具有较高的收率和高至高的对映体比率,并带有季螺立体中心。
  • Generation of α-Iminyl Radicals from α-Bromo Cyclic <i>N</i> -Sulfonylimines and Application to Coupling with Various Radical Acceptors Using a Photoredox Catalyst
    作者:Naoto Esumi、Kensuke Suzuki、Yoshihiro Nishimoto、Makoto Yasuda
    DOI:10.1002/chem.201704060
    日期:2018.1.9
    Visible‐light‐induced generation of α‐iminyl radicals was accomplished using α‐bromo cyclic N‐sulfonylimines and photoredox catalysts such as erythrosine B or Ru(bpy)3(PF6)2. The generated α‐iminyl radical was utilized for various radical reactions with allylation reagents, silyl enol ethers and allenyl stannane to give the corresponding coupling products. Furthermore, atom transfer radical addition
    可见光诱导的α-亚基自由基的产生是通过使用α-代环状N-磺酰亚胺碱和光氧化还原催化剂如赤藓红B或Ru(bpy)3(PF 6)2来实现的。产生的α-亚基自由基可用于与烯丙基化试剂,甲硅烷基烯醇醚和烯丙基烷的各种自由基反应,以产生相应的偶联产物。此外,进行向烯烃的原子转移自由基加成(ATRA)以提供ATRA产物。该过程为合成具有生物活性化合物并成为阿ult合成的前体的环状N-磺胺基林分子提供了温和而有效的方法。
  • W-Phos Ligand Enables Copper-Catalyzed Enantioselective Alkylation of <i>N</i>-Sulfonyl Ketimines with Grignard Reagents
    作者:Li-Ming Zhang、Wenjun Luo、Jiangzhen Fu、Yu Liu、Junliang Zhang
    DOI:10.1021/acscatal.3c01775
    日期:2023.7.7
    reagents to ketimines poses a considerable challenge. Herein, a PNP-type W-Phos ligand developed recently by our group showed a unique effect toward this end, paving the way to a Cu(I)-catalyzed asymmetric alkylation reaction of N-sulfonyl ketimines, delivering optically active α-tertiary amines in high enantioselectivities. This catalytic protocol shows an unprecedented substrate scope with more than
    反应性格氏试剂与酮亚胺的催化不对称加成提出了相当大的挑战。在此,我们课题组最近开发的PNP型W-Phos配体对此表现出了独特的作用,为Cu(I)催化N-磺酰酮亚胺的不对称烷基化反应铺平了道路,从而提供光学活性的α-叔胺具有高对映选择性。该催化方案显示了前所未有的底物范围,包含 80 多个示例,不仅与苯并五元和六元环状N-磺酰酮亚胺兼容,而且还适用于几何不稳定(E或Z)无环N-磺酰酮亚胺。该方案的应用潜力在于天然产物和药物化合物中广泛存在α-叔胺,并且通过维持对映选择性的下游转化也证明了这一点。
查看更多

同类化合物

6-乙氧基-2-甲基-5,6-二氢-1,4-氧硫杂环己二烯-3-羧酸 5,6-二氢-1,4-氧硫杂环己二烯-2-羧酸 5,6,7,8-四氢-4,7-二甲基-1,2-苯并氧硫杂环己二烯 2,2-二氧化物 2-甲基-5,6-二氢-1,4-氧硫杂环己二烯-3-甲酸 2-甲基-1,4-氧硫杂环己二烯-3-羧酸 1-(6-乙氧基-2-甲基-4-氧代-5,6-二氢-1,4-氧硫杂环己二烯-3-基)乙酮 1,4-苯并氧硫杂环己二烯4,4-二氧化物 1,4-氧硫杂环己二烯 1,4-噁噻英,2,3-二氢-5,6-二甲基- 1,2-苯并噁噻英,3,4-二氢- 1,2-氧硫杂环己二烯 5,6-dihydro-[1,4]oxathiine-2,3-dicarboxylic acid dimethyl ester (6-[1,3]Dithian-2-ylmethyl-benzo[1,3]dioxol-5-yl)-carbamic acid tert-butyl ester 2,6-dimethyl-4-(1,1,3,3-tetraoxo-1λ6,3λ6-[1,3]dithietan-2-ylidene)-4H-pyran Pyrrolidine,1-(3-chloro-3,4,5,6,7,8-hexahydro-2,2-dioxido-1,2-benzoxathiin-4-yl)-,trans- β-Methyl-β-dimethylamino-pent-3-en-sulfonsaeure-sulton (2,2-Dioxo-6-phenyl-3,4-dihydro-2H-2λ6-[1,2]oxathiin-4-yl)-diethyl-amine 6,12,18,24,25,27,29,31-octachloro-2,8,14,20-tetraoxa-3λ6,9λ6,15λ6,21λ6-tetrathiapentacyclo[20.2.2.24,7.210,13.216,19]dotriaconta-1(25),4(32),5,7(31),10(30),11,13(29),16(28),17,19(27),22(26),23-dodecaene 3,3,9,9,15,15,21,21-octaoxide O-methyl-(5,6-dihydro-2-methyl-1,4-oxathiin-3-yl)carbonyl carbamothioate 6-tert-Butyl-N,N,2-trimethyl-4-oxo-4H-3,1-benzoxathiin-8-carboxamid-1-oxid Dimethyl-(4-methyl-2,2-dioxo-3,6-dihydro-2H-2λ6-[1,2]oxathiin-5-yl)-amine (2S,6S)-2,6-Diethyl-4-ethylsulfanyl-5-methyl-6H-[1,3]oxathiine 5,6-dihydro-2-methyl-1,4-oxathiin-3-carboxylic acid hydrazide 18-methoxy-5,8,11-trioxa-2,14-dithia-18-azabicyclo[13.2.1]octadeca-1(17),15-diene 9',10'-dihydrospiro[cyclohexane-1,11'-[9,10](epithiooxymethano)anthracene] 13',13'-dioxide 6-(Morpholin-4-methyl)-2-(4-morpholinyl)-1,4,3-oxathiazin-4,4-dioxid 3-Methoxy-1,8,8-trioxo-2-oxa-8λ6-thia-spiro[4.5]deca-6,9-diene-3-carboxylic acid methyl ester 41,42-dimethoxy-5,8,11,14,25,28,31,34-octaoxa-2,17,22,37-tetrathia-41,42-diazatricyclo[36.2.1.118,21]dotetraconta-1(40),18,20,38-tetraene 35,36-dimethoxy-5,8,11,22,25,28-hexaoxa-2,14,19,31-tetrathia-35,36-diazatricyclo[30.2.1.115,18]hexatriaconta-1(34),15,17,32-tetraene 2,2-dimethyl-4-phenyl-6,6-bis-trifluoromethyl-6H-[1,3,5]oxathiazine 3-(1,1,2,2,3,3-hexafluoropropyl)-4-thia-2-hexen-6-olide 21-methoxy-5,8,11,14-tetraoxa-2,17-dithia-21-azabicyclo[16.2.1]henicosa-1(20),18-diene 3-bromo-4,6-diphenyl-[1,2]-oxathiine 2,2-dioxide (Z)-7,8-Dihydro-4H-1,3-oxathiocin-2-one (E)-4-Methyl-7,8,9,10-tetrahydro-4H-[1,3]oxathiecin-2-one 1-(2,2-Dioxo-3,4,7,8-tetrahydro-2H,5H-2λ6-thiopyrano[3,4-e][1,2]oxathiin-4-yl)-piperidine 1-(2,2-Dioxo-3,4,5,6-tetrahydro-2H-2λ6-thieno[3',2':3,4]benzo[1,2-e][1,2]oxathiin-4-yl)-piperidine 24-methoxy-5,8,11,14,17-pentaoxa-2,20-dithia-24-azabicyclo[19.2.1]tetracosa-1(23),21-diene 47,48-dimethoxy-5,8,11,14,17,28,31,34,37,40-decaoxa-2,20,25,43-tetrathia-47,48-diazatricyclo[42.2.1.121,24]octatetraconta-1(46),21,23,44-tetraene 5-Isopropyl-2,3-dihydro-[1,4]oxathiine 1-(2,2-Dioxo-3,4,5,6-tetrahydro-2H-2λ6-thieno[3',2':3,4]benzo[1,2-e][1,2]oxathiin-4-yl)-pyrrolidine (5,6-dihydro-1,4-oxathiin-3-yl)acetic acid 2-(2-Methyl-allyl)-1-(2-methyl-5,6-dihydro-[1,4]oxathiine-3-carbonyl)-isothiourea 6-ethoxy-5,6-dihydro-2-methyl-1,4-oxathiin-3-carbonyl chloride 6-Cyclopropyl-2,3-dihydro-1,4-oxathiine-5-carboxylic acid 2-Methyl-6-(trifluoromethyl)-2,3-dihydro-1,4-oxathiine-5-carboxylic acid 3-Methyl-6-(trifluoromethyl)-2,3-dihydro-1,4-oxathiine-5-carboxylic acid 3,4,6-trimethyl-[1,2]oxathiin-2,2-dioxide 2-Methyl-4-heptyl-butadien-(1.3)-sulton-(1.4)